128837-29-6

Basic information

• Product Name: 2,4-bis(ethoxymethoxy)benzaldehyde
• Synonyms: 2,4-bis(ethoxymethoxy)benzaldehyde
• CAS NO: 128837-29-6
• Molecular Weight: 254.283
• Mol File: 128837-29-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2,4-bis(ethoxymethoxy)benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-bis(ethoxymethoxy)benzaldehyde(128837-29-6)
• EPA Substance Registry System: 2,4-bis(ethoxymethoxy)benzaldehyde(128837-29-6)

Safety Data

• Hazardous Substances Data: 128837-29-6(Hazardous Substances Data)

Upstream product

• 7087-68-5 N-ethyl-N,N-diisopropylamine 
• 95-01-2 2,4-Dihydroxybenzaldehyde 
• 3188-13-4 ethyl chloromethyl ether 

Downstream Products

• 1083312-63-3 2,4-bis(ethoxymethoxy)phenol 
• 1083312-64-4 2,4-bis(ethoxymethoxy)-1-methoxybenzene 
• 1083312-66-6 2,4-bis(ethoxymethoxy)-1-isopropoxybenzene 
• 1400930-55-3 4-((2-ethyloxy)methoxy)-2-hydroxybenzaldehyde 
• 128837-33-2 7,2′,4′–trihydroxyflavanone 
• 25972-30-9 (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one 

Relevant articles and documents

NOVOBIOCIN ANALOGUES AND TREATMENT OF POLYCYSTIC KIDNEY DISEASE

Novobiocin analogues are useful in methods of treating, inhibiting, and/or preventing cyst formation in autosomal dominant polycystic kidney disease (ADPKD) in a subject. The disclosure provides methods of treating ADPKD comprising administering a therapeutically effective amount of a coumarin-3-carboxamide novobiocin analogue. Accordingly, the method can include administering a novobiocin analogue in a therapeutically effective amount for reducing levels of mTOR pathway phosphoproteins P-mTOR, P-Akt and P-S6K, or combinations thereof. Further, the method can include administering a novobiocin analogue in a therapeutically effective amount for reducing levels of Hsp-90 client proteins CFTR, ErbB2, c-Raf and Cdk4, or combinations thereof.

Convenient synthesis of polyhydroxy flavonoids

-